Blood test breakthrough could personalize Crohn's treatment
NCT ID NCT03142321
Summary
This study aimed to help doctors predict which patients with Crohn's disease affecting the small intestine would respond well to the medication vedolizumab. Researchers followed 48 adult patients already starting this treatment, using MRI scans and blood tests to look for patterns. The goal was to identify biological markers in the blood that could signal whether the treatment would work, allowing for more personalized care decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CROHN DISEASE OF SMALL INTESTINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.